Globus Medical Stock Forecast

Stock Price Forecast

According to 13 analysts polled by S&P Global, Globus Medical stock has a consensus rating of "Buy" and an average price target of $108.64. The average 1-year stock price forecast is 39.41% higher than the current stock price, while the lowest is $87 (+11.64%) and the highest is $122 (+56.55%).

Price Target: $108.64 (+39.41%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$87	$108.64	$115	$122
Change	+11.64%	+39.41%	+47.57%	+56.55%

Analyst Ratings

The average analyst rating for Globus Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	6	6	6	5	6	6
Buy	5	5	4	4	3	3
Hold	4	4	4	4	4	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	15	15	14	13	13	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ryan Zimmerman BTIG	BTIG	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Jun 23, 2026
Mathew Blackman TD Cowen	TD Cowen	Buy Maintains $115	Buy	Maintains	$115	+47.57%	Jun 22, 2026
Matthew O'Brien Piper Sandler	Piper Sandler	Buy Maintains $115 → $100	Buy	Maintains	$115 → $100	+28.32%	Jun 15, 2026
Matt Miksic Barclays	Barclays	Buy Maintains $123	Buy	Maintains	$123	+57.83%	May 11, 2026
Richard Newitter Truist Financial	Truist Financial	Buy Maintains n/a	Buy	Maintains	n/a	n/a	May 8, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

3.20B

from 2.94B

8.98%

from 2.94B

Revenue Next Year

3.40B

from 3.20B

6.29%

from 3.20B

EPS This Year

4.74

from 3.98

19.17%

from 3.98

EPS Next Year

5.15

from 4.74

8.48%

from 4.74

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	958.10M	1.02B	1.57B	2.52B	2.94B	3.20B
Revenue Growth	21.43%	6.76%	53.35%	60.62%	16.65%	8.98%
Gross Profit	718.88M	760.01M	1.09B	1.70B	2.00B	2.23B
Gross Margin	75.03%	74.30%	69.62%	67.46%	68.07%	69.70%
Operating Income	194.86M	237.15M	273.51M	441.03M	600.27M	753.85M
Net Income	149.19M	190.17M	122.87M	102.98M	537.87M	541.51M
EPS	-	-	-	-	3.98	4.74
EPS Growth	-	-	-	-	30.92%	19.17%
Forward PE	33.48	32.74	20.76	25.54	21.59	16.43
Free Cash Flow	160.53M	75.52M	-346.13M	597.73M	327.53M	449.40M
No. Analysts	-	-	-	-	-	13

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	3.2B
Avg	3.2B
Low	3.2B

Revenue Growth

Revenue Growth	2026	2027	2028
High	9.6%
Avg	9.0%
Low	8.6%

EPS Forecast

EPS	2026	2027	2028
High	4.78
Avg	4.74
Low	4.70

EPS Growth

EPS Growth	2026	2027	2028
High	20.1%
Avg	19.2%
Low	18.1%